SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

RHIM (RHIM) News

Follow RHIM (RHIM) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 11 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol RHIM Asset market Sector Markets 90 days 11 Updated Sep 30, 2026, 11:18 AM UTC Open live news feed
L Man Group PLC: Form 8.3 - RHI Magnesita N.V. FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION2. POSITIONS OF THE PERSON MNA | Sep 30, 2026, 11:18 AM UTC H FTSE 100 hits two-week low as energy stocks slide London's FTSE 100 slipped to a two-week low on Tuesday, dragged down by heavyweight energy stocks as oil prices retreated, while British American Tobacco fell after issuing downbeat guidance.The blue-chip FTSE 100 index COMMODITIES | Sep 29, 2026, 04:25 PM UTC L Mergers and acquisitions The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Tuesday:** Britain's Vesuvius LSE:VSVS said that Austria-based RHI Magnesita N.V LSE:RHIM proposed to buy the metal flow engineering fi EQUITY | Sep 29, 2026, 01:34 PM UTC H RHI Magnesita, Vesuvius Merger Seems Attractive, RBC Says — Market Talk A merger between RHI Magnesita and Vesuvius is strategically sound, but could face competition issues, RBC Capital Markets analysts write. Iron foundries company Vesuvius said it received an offer approach worth 549 penc MNA | Sep 29, 2026, 11:26 AM UTC L FTSE 100 rises as AstraZeneca lifts healthcare sector London's FTSE 100 rose on Tuesday, lifted by pharmaceutical stocks after AstraZeneca agreed to take a $2 billion stake in Summit Therapeutics to advance cancer research.The blue-chip FTSE 100 index CURRENCYCOM:UK100 rose NEWS | Sep 29, 2026, 09:47 AM UTC L Vesuvius evaluating £1.37bn takeover proposal from RHI Magnesita Responding to recent media speculation, Veusvius said that since September last year, it has received a series of unsolicited non-binding indicative proposals from RHI. The latest proposal, received on 27 August, was of MNA | Sep 29, 2026, 09:40 AM UTC L UK's Vesuvius weighs Austria-based rival RHI Magnesita's £1.37 billion bid; shares jump British engineering firm Vesuvius LSE:VSVS said on Tuesday it was assessing a £1.37 billion ($1.81 billion) cash-and-stock bid from Austria-based RHI Magnesita N.V LSE:RHIM, sending shares up 31%.The bid comes after Vesu EQUITY | Sep 29, 2026, 08:46 AM UTC L UK's Vesuvius receives takeover proposal from RHI Magnesita N.V Britain's Vesuvius LSE:VSVS said on Tuesday that Austria-based RHI Magnesita N.V LSE:RHIM proposed to buy the metal flow engineering firm in a cash-and-stock bid valued at 551 pence per share, after it rejected its previ MNA | Sep 29, 2026, 07:51 AM UTC L RHI Magnesita expands India capabilities with local R&D, robotic automation India’s manufacturing push is moving beyond adding production capacity, with global industrial companies increasingly focusing on developing local capabilities in technology, research, supply chains, automation and talen NEWS | Sep 25, 2026, 12:38 PM UTC L Dalmia Bharat Refractories sells 11.11% stake in RHI Magnesita India for ₹826 crore Dalmia Bharat Refractories on Tuesday divested more than an 11 per cent stake in RHI Magnesita India for Rs 826 crore through an open market transaction.RHI Magnesita India is one of the leading suppliers of high-grade r NEWS | Sep 23, 2026, 02:27 AM UTC M RHI Magnesita India block deal: Dalmia Bharat Refractories sells 11.11% Dalmia Bharat Refractories sold an 11.11% stake in RHI Magnesita India in an NSE block deal on Tuesday, raising around ₹826 crore. MNA | Sep 22, 2026, 03:12 PM UTC